Search the Newsreel

NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary

ICU Medical (ICUI) Q2 2026 Earnings Call Transcript

AK Medical Sets August Board Meeting to Review Interim Results and Dividend

Insider Stock Buying Reaches CN¥264.4m On Shanghai INT Medical Instruments

ICU Medical VP Daniel Woolson sells $982,264 in stock

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc. (NASDAQ:ICUI), sold 5,417 shares of the company's common stock for $982,264 on August 13, 2026, at $181.33 per share. This sale occurred as ICUI shares are near their 52-week high, following strong Q2 results where …

Profound Medical (PROF) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer and Chairman - Arun Swarup MenawatPresident - Mathieu BurtnykChief Commercial Officer - Tom TamberrinoCorporate Controller - Matthew SobczykInvestor Relations - Stephen Kilmer TAKEAWAYS Revenue -- …

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Corporate Communications - Ben Atkins President and Chief Executive Officer - Cary G. Vance Chief Financial Officer - David O'Toole Need a …

Rockwell Medical Inc (RMTI) (Q2 2026) Earnings Call Highlights: Revenue Up 11% and Cash Flow ...

ICU Medical (ICUI) officer Daniel Woolson sells 5,417 shares at $181.33

Daniel Woolson, VP and GM-Infusion Capital at ICU Medical Inc. (ICUI), sold 5,417 shares of common stock at $181.33 per share on August 13, 2026. After this transaction, Woolson directly holds 17,062 shares of ICU Medical common stock. The sale was not conducted under …

Earnings call transcript: Tenon Medical posts strong growth in Q2 2026

Tenon Medical reported strong revenue growth of 127% year-over-year in Q2 2026, reaching $1.3 million, but still posted a wider net loss of $4.1 million and missed analyst expectations for both revenue and earnings. Despite the financial miss, the company saw significant gross margin …

MNOV: Q2 2026 revenue grew and net loss narrowed, with cash reserves supporting operations into 2027

MediciNova (MNOV) reported a revenue increase to $0.5M in Q2 2026, primarily from Mayo ALS study services, while significantly narrowing its net loss to $2.3M. Research and development expenses decreased year-over-year, and the company's $25.4M in cash reserves are projected to fund operations until …

Strata Critical Medical (SRTA) director Reginald Love sells 5,091 shares at $5.75

Strata Critical Medical, Inc. director Reginald Love sold 5,091 shares of Class A common stock at $5.75 per share on August 10, 2026. Following this transaction, his direct holdings in the company amount to 146,481 shares. The sale was reported in an open market …

Adagio Medical Highlights VT Ablation Progress in Presentation

Modern Chinese Medicine Group Sets August Board Meeting for Interim Results and Dividend Review

Farallon funds disclose 13.6M-share RVMD stake in Schedule 13G/A filing

Farallon Capital Management, L.L.C. and its affiliated funds have disclosed a beneficial ownership of 13,564,149 shares, or 6.4%, of Revolution Medicines, Inc. (RVMD) common stock, according to a recent Schedule 13G/A filing. This includes 13,550,796 shares and 120,085 common stock purchase warrants, with the …

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI) reported a quarterly loss of $0.07 per share, exceeding analyst estimates by $0.01. Despite beating expectations, shares fell 2.2% to $1.34. The company has an average "Hold" rating from analysts with a target price of $3.75, and director Gregg Williams recently …

Tenon Medical, Inc. 2Q 2026: Revenue $1.279M, Net loss $(4.05M), EPS $(12.35) — 10-Q Summary

Tenon Medical, Inc. reported its second-quarter 2026 results, showing revenue of $1.279 million, a net loss of $(4.05 million), and a diluted loss per share of $(12.35). Revenue more than doubled year-over-year, driven by increased procedure volumes and the acquisition of the SImmetry+ System. …

Tenon Medical (TNON) lifts SI joint revenue but flags going-concern risk

Tenon Medical (TNON) reported increased revenue for the quarter ended June 30, 2026, reaching $1.3 million, up from $0.6 million a year prior, driven by higher SI joint procedure volumes and contributions from its SImmetry+ system. Despite revenue growth and improved gross margins, the …

Medical Properties Trust, Inc. Declares Regular Quarterly Dividend, Payable on October 8, 2026

Medical Properties Trust, Inc. announced a regular quarterly cash dividend of $0.09 per share of common stock. This dividend will be paid on October 8, 2026, to shareholders of record as of September 10, 2026. The announcement was made by the company's Board of …

Vivani Medical: Q2 Earnings Snapshot

Renaissance Technologies (UTMD) discloses 5.52% ownership in Utah Medical Products

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a beneficial ownership of 175,814 shares, or 5.52%, in Utah Medical Products Inc. as of June 30, 2026. Both entities hold sole voting and dispositive power over these shares. The filing, a Schedule 13G/A, …

IceCure Medical (Nasdaq: ICCM) updates filing for 533,334 warrant-share resales

IceCure Medical Ltd. has filed a post-effective amendment to its Form F-1 to update financial information and maintain the effectiveness of a resale registration. This filing concerns the potential resale of up to 533,334 Ordinary Shares by existing selling shareholders, which are issuable upon …

IceCure Medical (ICCM) details 324,802-share warrant issuance and $9.7M potential proceeds

IceCure Medical Ltd. has filed a post-effective amendment to register the issuance of up to 324,802 Ordinary Shares upon the exercise of outstanding warrants from a previous rights offering. The exercise includes warrants at $30.00 per share and pre-funded warrants at $0.003 per share, …

Profound Medical (PROF) launches global ‘Let’s Huddle’ prostate patient community

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) announced the launch of "Let's Huddle," a global patient advocacy and community initiative for men navigating prostate care. Led by former NFL player and prostate cancer survivor Leonard Wheeler, the program aims to provide education, peer support, and resources …

Adagio Medical updates investor presentation; expects FDA PMA approval for vCLAS in Q4 2026, $7.7M cash

Adagio Medical has released an updated investor presentation detailing its ULTA technology and clinical program. Key highlights include the full enrollment of the FULCRUM‑VT pivotal trial, projected FDA PMA approval for its first-gen vCLAS in Q4 2026, and $7.7 million in cash as of …

Mobia Medical (MOBI) investors report up to 11.6% ownership in Schedule 13G

U.S. Venture Partners XII, L.P., Presidio Management Group XII, L.L.C., and Casey M. Tansey have filed a Schedule 13G disclosing significant ownership stakes in Mobia Medical, Inc. (MOBI). U.S. Venture Partners XII, L.P. holds 5.7%, Presidio Management Group XII, L.L.C. holds 10.9%, and Casey …

Tenon Medical Q2 Revenue Rises 127% to $1.3 Million

Tenon Medical (TNON) reported a significant increase in its Q2 2026 revenue, rising 127% to $1.3 million, with gross profit up 232% to $0.8 million. The company also announced FDA 510(k) clearance for its updated Catamaran SI Joint Fusion System and completed a $4.2 …

MPT Declares Regular Quarterly Dividend

BIRMINGHAM, Ala., August 13, 2026--(BUSINESS WIRE)--MPT (the "Company" or "MPT") (NYSE: MPT) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on October 8, 2026, to stockholders of record on …

Modular Medical (MODD) investor group discloses 6.23% stake and warrant overhang

An investor group led by Bleichroeder LP has disclosed a 6.23% beneficial ownership stake in Modular Medical, Inc. (MODD), totaling 336,986 common shares with sole voting and dispositive power. The group also holds warrants for an additional 110,092 shares, but their exercise is subject …

Wellington entities report 11.6% stake in Dick's Sporting Goods (DKS)

Wellington Management Group LLP and its related entities have reported a beneficial ownership of 7,673,983 shares of Dick's Sporting Goods, Inc. common stock, which accounts for 11.64% of the class. These shares are held for advisory clients, with shared voting power over 6,981,208 shares …

Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027

Vivani Medical (VANI) has reported a net loss of $6.4 million for Q2 2026 and $13.2 million for the first half of 2026, with cash and equivalents totaling $19.9 million, which is projected to fund operations into Q2 2027. The company is advancing its …

Form 8K Vivani Medical Inc For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 13th, as tracked by Investing.com. The brief mention indicates a financial disclosure event for the company, with the stock symbol VANI noted to have experienced a -2.19% change.

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …

20 Participants Dosed in Semaglutide Trial; Data Due in November

Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …

Tenon Medical (TNON) posts 127% Q2 2026 revenue growth amid higher net loss

Tenon Medical reported a significant revenue increase of 127% to $1.3 million in Q2 2026, driven by higher surgical procedures and the SImmetry®+ System, alongside an improved gross margin of 64%. Despite this growth, the company's net loss widened to $4.1 million, and it …

Tenon Medical Reports Second Quarter 2026 Financial Results

Tenon Medical (NASDAQ:TNON) announced its second quarter 2026 financial results, reporting a 127% increase in revenue to $1.3 million and a 232% increase in gross profit to $0.8 million compared to the prior year. The company also received FDA 510(k) clearance for its updated …